FDA Adverse Event Injury Summary report: N

PROMUS PREMIER

MDR report key: 8157611 · Received December 12, 2018

Report

Report Number
2134265-2018-63745
Event Type
Injury
Date Received
December 12, 2018
Date of Event
November 14, 2018
Report Date
December 12, 2018
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NIQ
UDI-DI
08714729844648
PMA / PMN Number
P110010
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. (B)(6).

Description of Event or Problem · 1

IT WAS REPORTED THAT ARTERY DISSECTION OCCURRED. THE TARGET LESION WAS LOCATED IN THE LEFT ANTERIOR DESCENDING ARTERY. A 2.25X12MM PROMUS PREMIER DRUG-ELUTING STENT WAS USED FOR TREATMENT, BUT FAILED TO CROSS THE LESION. WHEN THE PHYSICIAN TRIED TO REMOVE THE DEVICE THE ARTERY A NON FLOW LIMITING DISSECTION OCCURRED. THE PHYSICIAN USED A DIFFERENT DEVICE TO OVERLAP THE DISSECTED ARTERY. NO SERIOUS INJURY AND NO FURTHER COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
994259 PROMUS PREMIER STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC CORPORATION 9583 0022211916 08714729844648

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention